Meier Thomas Oleg, Jacomella Vincenzo, Clemens Robert Karl Josef, Amann-Vesti Beatrice
1 Clinic for Angiology, University Hospital Zurich, Switzerland.
Vasa. 2015 Nov;44(6):473-8. doi: 10.1024/0301-1526/a000471.
Tumescent anaesthesia (TA) is an important but sometimes very painful step during endovenous thermal ablation of incompetent veins. The aim of this study was to examine whether the use of fixed 50% nitrous oxide/oxygen mixture (N2O/O2), also called equimolar mixture of oxygen and nitrous oxide, reduces pain during the application of TA.
Patients undergoing endovenous laser ablation (EVLA) of incompetent saphenous veins were included. Thirty consecutive patients inhaled N2O/O2 during the application of TA. Thirty consecutive patients received TA alone (controls). Patients were asked to complete a questionnaire immediately after the intervention to assess satisfaction with the intervention and pain-levels during the different steps of the intervention (0=not at all, 10=very much). Adverse events during the treatment were monitored.
30 patients (14 men, mean age of 44 years) were included in the N2O/O2 group and 30 patients (9 men, mean age 48 years) were included in the control group. In the N2O/O2 group a significantly lower pain score was noted (mean 2.45 points, range 0-6) compared to the controls (mean 4.3 points, range 1-9, p<0.001). Overall, 64.5% of the patients were perfectly satisfied with the N2O/O2-Inhalation. Only 4 patients receiving N2O/O2 complained of adverse effects such as unpleasant loss of control (2 patients), headache (1 patient) and dizziness (1 patient).
N2O/O2 is a safe and effective method to reduce pain during the application of tumescent anaesthesia for EVLA.
肿胀麻醉(TA)是静脉内热消融功能不全静脉过程中的一个重要步骤,但有时非常痛苦。本研究的目的是检验使用固定的50%氧化亚氮/氧气混合气体(N2O/O2),即所谓的氧气和氧化亚氮等摩尔混合物,是否能减轻TA应用过程中的疼痛。
纳入接受大隐静脉功能不全的静脉内激光消融(EVLA)的患者。30例连续患者在TA应用过程中吸入N2O/O2。30例连续患者仅接受TA(对照组)。干预结束后,要求患者立即完成一份问卷,以评估对干预的满意度以及干预不同步骤中的疼痛程度(0 = 完全没有,10 = 非常严重)。监测治疗期间的不良事件。
N2O/O2组纳入30例患者(14例男性,平均年龄44岁),对照组纳入30例患者(9例男性,平均年龄48岁)。与对照组(平均4.3分,范围1 - 9分,p<0.001)相比,N2O/O2组的疼痛评分显著更低(平均2.45分,范围0 - 6分)。总体而言,64.5%的患者对吸入N2O/O2非常满意。仅4例接受N2O/O2的患者抱怨有不良反应,如令人不适的失控感(2例患者)、头痛(1例患者)和头晕(1例患者)。
N2O/O2是一种安全有效的方法,可减轻EVLA肿胀麻醉应用过程中的疼痛。